Skip to main content
OpenTrials
Completed

NCT Number: NCT00894231

Levocetirizine Effect on Nasal Nitric Oxide and Nasal Eosinophils in Subjects With Perennial Allergic Rhinitis

The purpose of this study is to noninvasively measure the anti-inflammatory effect of levocetirizine after two weeks of treatment in allergic rhinitis subjects.

Completed

Looking for future studies?

Notify Me

Key information

Age range

12 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

AAADRS

Coral Gables, Florida, 33134, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • ICF signed
  • Diagnosis of PAR for 6-12 months greater
  • 12 years and older
  • Decreased nasal NO values at baseline
  • Compliance and ability to perform maneuvers and responsibilities

Exclusion criteria

  • Oral or systemic steroids for 60 days prior
  • Inhaled, nasal, nebulized steroids w/i 4 weeks
  • Hospitalization or life threatening asthma
  • Use of nasal or oral antihistamines w/i 4 weeks
  • Upper or lower airways infection
  • Direct cigarette smoke exposure

Treatment and study plan

levocetirizine (Xyzal)

Drug

5mg po QD

Other names: Xyzal

Placebo

Drug

sugar tablet

Primary outcomes

  1. The change in objective measure of inflammation nasal NO after LC treatment.

    Time frame: two weeks

Secondary outcomes

  1. The change in nasal eosinophils, QOL and diary scores after LC treatment.

    Time frame: two weeks

Sponsors and collaborators

Lead sponsor

AAADRS Clinical Research Center

Other

Collaborators

  • UCB Pharma

Registry information

Important dates

Study start
2009
Primary completion
2009
Study completion
2009
First posted
May 6, 2009
Registry last updated
Sep 4, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.